International Business News - ZGEN http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Drug developer ZymoGenetics Inc. said Wednesday it filed a registration statement with the Securities and Exchange Commission that will allow it to sell up to $100 million in common stock. http://www.ibtimes.com/articles/20081126/zymogenetics-files-statement-to-sell-stock.htm Wed, 26 Nov 2008 09:02:04 EST Drug developer ZymoGenetics Inc. said Friday Chief Executive Bruce Carter will retire Jan. 2 and be succeeded by President and Chief Scientific Officer Douglas Williams. http://www.ibtimes.com/articles/20081121/zymogenetics-says-ceo-bruce-carter-to-retire.htm Fri, 21 Nov 2008 09:52:37 EST Among the stock activity stories for Friday, Nov. 7, from AP Financial News: NEW YORK (AP)--Shares of Qualcomm Inc., the world's largest designer of cell phone chips, moved higher Friday despite a weak outlook for the wireless market. http://www.ibtimes.com/articles/20081107/movers-roundup-qualcomm-genworth-financial.htm Fri, 07 Nov 2008 14:42:53 EST Shares of ZymoGenetics Inc. rose Friday after an Oppenheimer analyst upgraded the stock, saying Wall Street now has a more reasonable view of the stock, and more modest expectations for the company's blood clotting drug Recothrom. http://www.ibtimes.com/articles/20081107/zymogenetics-rises-following-analyst-upgrade.htm Fri, 07 Nov 2008 15:28:41 EST Biotechnology drugmaker ZymoGenetics said Wednesday it restructured its agreement with partner Merck Serono for the development of treatment for autoimmune diseases. http://www.ibtimes.com/articles/20080903/zymogenetics-alters-drug-development-agreements.htm Wed, 03 Sep 2008 13:13:29 EDT Drug developer ZymoGenetics Inc. will receive a $5 million payment from Bayer HealthCare as part of an agreement between the companies to sell the blood-clotting drug Recothrom. http://www.ibtimes.com/articles/20080902/zymogenetics-reaps-5m-payment-from-recothrom-deal.htm Tue, 02 Sep 2008 10:19:24 EDT Drug developer ZymoGenetics Inc. said Monday it has received $100 million in financing from shareholder Deerfield Management. Under terms of the agreement, Deerfield has committed $100 million that can be drawn in $25 million tranches at any time over the next 18 months. Each tranche will entitle Deerfield to a royalty of 2 percent of sales of the company's blood-clotting drug Recothrom. http://www.ibtimes.com/articles/20080630/zymogenetics-gets-100m-investment-from-holder.htm Mon, 30 Jun 2008 07:36:33 EDT ZymoGenetics Inc. said Tuesday the Food and Drug Administration approved a larger vial size for the biotechnology company's blood-clotting drug Recothrom Thrombin. http://www.ibtimes.com/articles/20080527/zymogenetics-gets-ok-for-blood-clotting-drug-size.htm Tue, 27 May 2008 10:19:06 EDT Among the earnings stories for Tuesday, May 6, from AP Financial News: LOUISVILLE, Ky. (AP) _ Churchill Downs Inc., which operates the home of the Kentucky Derby and other racetracks, said Tuesday it swung to a profit in its first quarter mainly due to a big gain for insurance recoveries. http://www.ibtimes.com/articles/20080506/earnings-roundup-churchill-downs-zymogenetics.htm Tue, 06 May 2008 18:34:27 EDT